Cargando…
Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
BACKGROUND: We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 1...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873241/ https://www.ncbi.nlm.nih.gov/pubmed/20388219 http://dx.doi.org/10.1186/1742-2094-7-25 |
_version_ | 1782181294666416128 |
---|---|
author | Carlson, Noel G Rojas, Monica A Redd, Jonathan W Tang, Philip Wood, Blair Hill, Kenneth E Rose, John W |
author_facet | Carlson, Noel G Rojas, Monica A Redd, Jonathan W Tang, Philip Wood, Blair Hill, Kenneth E Rose, John W |
author_sort | Carlson, Noel G |
collection | PubMed |
description | BACKGROUND: We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 149:40). This suggests that COX-2 may contribute to death of oligodendrocytes. OBJECTIVE: The goal of this study was to examine whether COX-2 contributes to excitotoxic death of oligodendrocytes and potentially contributes to demyelination. METHODS: The potential link between COX-2 and oligodendrocyte death was approached using histopathology of MS lesions to examine whether COX-2 was expressed in dying oligodendrocytes. COX-2 inhibitors were examined for their ability to limit demyelination in the TMEV-IDD model of MS and to limit excitotoxic death of oligodendrocytes in vitro. Genetic manipulation of COX-2 expression was used to determine whether COX-2 contributes to excitotoxic death of oligodendrocytes. A transgenic mouse line was generated that overexpressed COX-2 in oligodendrocytes. Oligodendrocyte cultures derived from these transgenic mice were used to examine whether increased expression of COX-2 enhanced the vulnerability of oligodendrocytes to excitotoxic death. Oligodendrocytes derived from COX-2 knockout mice were evaluated to determine if decreased COX-2 expression promotes a greater resistance to excitotoxic death. RESULTS: COX-2 was expressed in dying oligodendrocytes in MS lesions. COX-2 inhibitors limited demyelination in the TMEV-IDD model of MS and protected oligodendrocytes against excitotoxic death in vitro. COX-2 expression was increased in wild-type oligodendrocytes following treatment with Kainic acid (KA). Overexpression of COX-2 in oligodendrocytes increased the sensitivity of oligodendrocytes to KA-induced excitotoxic death eight-fold compared to wild-type. Conversely, oligodendrocytes prepared from COX-2 knockout mice showed a significant decrease in sensitivity to KA induced death. CONCLUSIONS: COX-2 expression was associated with dying oligodendrocytes in MS lesions and appeared to increase excitotoxic death of oligodendrocytes in culture. An understanding of how COX-2 expression influences oligodendrocyte death leading to demyelination may have important ramifications for future treatments for MS. |
format | Text |
id | pubmed-2873241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28732412010-05-20 Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death Carlson, Noel G Rojas, Monica A Redd, Jonathan W Tang, Philip Wood, Blair Hill, Kenneth E Rose, John W J Neuroinflammation Research BACKGROUND: We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 149:40). This suggests that COX-2 may contribute to death of oligodendrocytes. OBJECTIVE: The goal of this study was to examine whether COX-2 contributes to excitotoxic death of oligodendrocytes and potentially contributes to demyelination. METHODS: The potential link between COX-2 and oligodendrocyte death was approached using histopathology of MS lesions to examine whether COX-2 was expressed in dying oligodendrocytes. COX-2 inhibitors were examined for their ability to limit demyelination in the TMEV-IDD model of MS and to limit excitotoxic death of oligodendrocytes in vitro. Genetic manipulation of COX-2 expression was used to determine whether COX-2 contributes to excitotoxic death of oligodendrocytes. A transgenic mouse line was generated that overexpressed COX-2 in oligodendrocytes. Oligodendrocyte cultures derived from these transgenic mice were used to examine whether increased expression of COX-2 enhanced the vulnerability of oligodendrocytes to excitotoxic death. Oligodendrocytes derived from COX-2 knockout mice were evaluated to determine if decreased COX-2 expression promotes a greater resistance to excitotoxic death. RESULTS: COX-2 was expressed in dying oligodendrocytes in MS lesions. COX-2 inhibitors limited demyelination in the TMEV-IDD model of MS and protected oligodendrocytes against excitotoxic death in vitro. COX-2 expression was increased in wild-type oligodendrocytes following treatment with Kainic acid (KA). Overexpression of COX-2 in oligodendrocytes increased the sensitivity of oligodendrocytes to KA-induced excitotoxic death eight-fold compared to wild-type. Conversely, oligodendrocytes prepared from COX-2 knockout mice showed a significant decrease in sensitivity to KA induced death. CONCLUSIONS: COX-2 expression was associated with dying oligodendrocytes in MS lesions and appeared to increase excitotoxic death of oligodendrocytes in culture. An understanding of how COX-2 expression influences oligodendrocyte death leading to demyelination may have important ramifications for future treatments for MS. BioMed Central 2010-04-13 /pmc/articles/PMC2873241/ /pubmed/20388219 http://dx.doi.org/10.1186/1742-2094-7-25 Text en Copyright ©2010 Carlson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Carlson, Noel G Rojas, Monica A Redd, Jonathan W Tang, Philip Wood, Blair Hill, Kenneth E Rose, John W Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
title | Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
title_full | Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
title_fullStr | Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
title_full_unstemmed | Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
title_short | Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
title_sort | cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873241/ https://www.ncbi.nlm.nih.gov/pubmed/20388219 http://dx.doi.org/10.1186/1742-2094-7-25 |
work_keys_str_mv | AT carlsonnoelg cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath AT rojasmonicaa cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath AT reddjonathanw cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath AT tangphilip cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath AT woodblair cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath AT hillkennethe cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath AT rosejohnw cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath |